Search

Your search keyword '"Umez-Eronini, Amarachi A."' showing total 26 results
Start Over Author "Umez-Eronini, Amarachi A."
26 results on '"Umez-Eronini, Amarachi A."'

1. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo

Author

Nieminen, Tuomo, Scirica, Benjamin M., Pegler, Jose R.M., Tavares, Caio, Pagotto, Vitor P.F., Kanas, Alexandre F., Sobrado, Marcel F., Nearing, Bruce D., Umez-Eronini, Amarachi A., Morrow, David A., Belardinelli, Luiz, and Verrier, Richard L.

Published
2014
Full Text
View/download PDF

5. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Author

Udell, Jacob A., Bhatt, Deepak L., Braunwald, Eugene, Cavender, Matthew A., Mosenzon, Ofri, Steg, Ph. Gabriel, Davidson, Jaime A., Nicolau, Jose C., Corbalan, Ramon, Hirshberg, Boaz, Frederich, Robert, Im, KyungAh, Umez-Eronini, Amarachi A., He, Ping, McGuire, Darren K., Leiter, Lawrence A., Raz, Itamar, and Scirica, Benjamin M.

Published
2015
Full Text
View/download PDF

10. Predictors of Long‐term Adherence to Evidence‐based Cardiovascular Disease Medications in Outpatients With Stable Atherothrombotic Disease: Findings From the REACH Registry

Author

Rodriguez, Fátima, Cannon, Christopher P., Steg, Ph. Gabriel, Kumbhani, Dharam J., Goto, Shinya, Smith, Sidney C., Eagle, Kim A., Ohman, E. Magnus, Umez‐Eronini, Amarachi A., Hoffman, Elaine, and Bhatt, Deepak L.

Subjects
Male, Health Knowledge, Attitudes, Practice, Time Factors, Medication Adherence, Residence Characteristics, Risk Factors, Ambulatory Care, Odds Ratio, Secondary Prevention, Humans, Prospective Studies, Registries, Aged, Quality and Outcomes, Chi-Square Distribution, Incidence, Racial Groups, Age Factors, Cardiovascular Agents, Middle Aged, Logistic Models, Treatment Outcome, Cardiovascular Diseases, Multivariate Analysis, Practice Guidelines as Topic, Female, Self Report
Abstract

BACKGROUND: Despite overall improvements in cardiovascular‐disease therapies and outcomes, medication nonadherence remains an important barrier to effective secondary prevention of atherothrombotic disease. HYPOTHESIS: Long‐term medication adherence in outpatients with stable atherothrombotic disease is impacted by demographic and clinical factors. METHODS: We examined data from the prospective international Reduction of Atherothrombosis for Continued Health (REACH) Registry. Analyses were derived from 25 737 patients with established atherothrombotic disease with complete adherence data at enrollment and at year 4. Adherence was defined as patients' self‐report of taking medications based on class I American College of Cardiology/American Heart Association guidelines for secondary prevention as defined, including antiplatelet agents, statins, and antihypertensive medications. RESULTS: Among patients with atherothrombotic disease, 12 500 (48.6%) were deemed adherent to guideline‐recommended medications. Adherent patients were younger, white, and had less polyvascular disease. Hispanic and East Asian patients were less likely to be adherent as compared with white patients (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.59‐0.88; and OR: 0.67, 95% CI: 0.53‐0.83, respectively). Patients who had a nonfatal MI or underwent coronary angioplasty/stenting during follow‐up were more likely to be adherent compared with patients without these events (OR: 1.73, 95% CI: 1.25‐2.38; and OR: 2.15, 95% CI: 1.72‐2.67, respectively). On the other hand, nonfatal stroke during follow‐up was inversely associated with adherence (OR: 0.77, 95% CI: 0.61‐0.97). CONCLUSIONS: Using a large international registry of outpatients with atherothrombotic disease, we found that age, region, race/ethnicity, and incident cardiovascular events were predictive of long‐term guideline adherence for secondary prevention, suggesting that certain patient groups may benefit from targeted interventions to improve adherence.

Published
2013

12. Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”

Author

Scirica, Benjamin M., primary, Braunwald, Eugene, additional, Raz, Itamar, additional, Cavender, Matthew A., additional, Morrow, David A., additional, Jarolim, Petr, additional, Udell, Jacob A., additional, Mosenzon, Ofri, additional, Im, KyungAh, additional, Umez-Eronini, Amarachi A., additional, Pollack, Pia S., additional, Hirshberg, Boaz, additional, Frederich, Robert, additional, Lewis, Basil S., additional, McGuire, Darren K., additional, Davidson, Jaime, additional, Steg, Gabriel, additional, and Bhatt, Deepak L., additional

Published
2015
Full Text
View/download PDF

14. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Author

Udell, Jacob A., primary, Bhatt, Deepak L., additional, Braunwald, Eugene, additional, Cavender, Matthew A., additional, Mosenzon, Ofri, additional, Steg, Ph. Gabriel, additional, Davidson, Jaime A., additional, Nicolau, Jose C., additional, Corbalan, Ramon, additional, Hirshberg, Boaz, additional, Frederich, Robert, additional, Im, KyungAh, additional, Umez-Eronini, Amarachi A., additional, He, Ping, additional, McGuire, Darren K., additional, Leiter, Lawrence A., additional, Raz, Itamar, additional, and Scirica, Benjamin M., additional

Published
2014
Full Text
View/download PDF

15. Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Author

Scirica, Benjamin M., primary, Braunwald, Eugene, additional, Raz, Itamar, additional, Cavender, Matthew A., additional, Morrow, David A., additional, Jarolim, Petr, additional, Udell, Jacob A., additional, Mosenzon, Ofri, additional, Im, KyungAh, additional, Umez-Eronini, Amarachi A., additional, Pollack, Pia S., additional, Hirshberg, Boaz, additional, Frederich, Robert, additional, Lewis, Basil S., additional, McGuire, Darren K., additional, Davidson, Jaime, additional, Steg, Ph. Gabriel, additional, and Bhatt, Deepak L., additional

Published
2014
Full Text
View/download PDF

16. PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL

Author

Scirica, Benjamin, primary, Bhatt, Deepak, additional, Braunwald, Eugene, additional, Raz, Itamar, additional, Steg, Philippe, additional, Davidson, Jaime, additional, Cavender, Matthew, additional, Hirshberg, Boaz, additional, Umez-Eronini, Amarachi, additional, Im, Kelly, additional, Jarolim, Petr, additional, and Morrow, David, additional

Published
2014
Full Text
View/download PDF

17. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis

Author

Udell, Jacob A, primary, Steg, Ph Gabriel, additional, Scirica, Benjamin M, additional, Eagle, Kim A, additional, Ohman, E Magnus, additional, Goto, Shinya, additional, Alsheikh-Ali, Alawi A, additional, Porath, Avi, additional, Corbalan, Ramon, additional, Umez-Eronini, Amarachi A, additional, Hoffman, Elaine B, additional, Wilson, Peter WF, additional, and Bhatt, Deepak L, additional

Published
2013
Full Text
View/download PDF

20. An ergonomics training program for student notebook computer users: Preliminary outcomes of a six-year cohort study

Author

Jacobs, Karen, primary, Kaldenberg, Jennifer, additional, Markowitz, Jackie, additional, Wuest, Ellen, additional, Hellman, Miranda, additional, Umez-Eronini, Amarachi, additional, Arsenault, Michael, additional, Walker, Bryce, additional, Hall, Victoria, additional, Ciccarelli, Marina, additional, Parsons, Richard, additional, and Barr, Alice, additional

Published
2013
Full Text
View/download PDF

25. Factors associated with preventive dental care-seeking behavior among people living with HIV.

Author

Tobias, Carol R., Lemay, Celeste A., Jeanty, Yves, Umez-Eronini, Amarachi A., and Reznik, David A.

Subjects
DENTAL care, HIV-positive persons, HIV, DENTAL insurance, ORAL hygiene
Abstract

Objectives: This study examined factors associated with preventive dental care-seeking behavior among HIV-positive adults who participated in a federally funded demonstration project to expand access to oral health care. Methods: Two thousand one hundred eighty-seven adults living with human immunodeficiency virus (HIV) in the United States were enrolled in free dental care and were interviewed about their reasons for seeking care, their oral health, and overall health status. Multivariate analysis using Generalized Estimating Equations to control for clustering by site was conducted to identify factors associated with preventive care-seeking behavior. Results: Forty-one percent of participants reported the only reason they sought dental care was for preventive care, to receive a checkup or cleaning. Factors associated with preventive care-seeking behavior in multivariate analysis included no unmet need for dental care since testing HIV positive, no dental insurance, taking HIV medications and better overall oral health. Conclusions: Many HIV-positive adults may seek preventive care when it is offered at no cost. Interventions that address unmet needs and target individuals who are not taking HIV medications or have poorer oral health may improve preventive practices. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

26. Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.

Author

Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, and Bhatt DL

Subjects
Age Factors, Aged, Cardiovascular Diseases diagnosis, Cardiovascular Diseases ethnology, Chi-Square Distribution, Female, Humans, Incidence, Logistic Models, Male, Middle Aged, Multivariate Analysis, Odds Ratio, Practice Guidelines as Topic, Prospective Studies, Racial Groups, Registries, Residence Characteristics, Risk Factors, Secondary Prevention standards, Self Report, Time Factors, Treatment Outcome, Ambulatory Care standards, Cardiovascular Agents therapeutic use, Cardiovascular Diseases drug therapy, Health Knowledge, Attitudes, Practice ethnology, Medication Adherence ethnology, Secondary Prevention methods
Abstract

Background: Despite overall improvements in cardiovascular-disease therapies and outcomes, medication nonadherence remains an important barrier to effective secondary prevention of atherothrombotic disease., Hypothesis: Long-term medication adherence in outpatients with stable atherothrombotic disease is impacted by demographic and clinical factors., Methods: We examined data from the prospective international Reduction of Atherothrombosis for Continued Health (REACH) Registry. Analyses were derived from 25 737 patients with established atherothrombotic disease with complete adherence data at enrollment and at year 4. Adherence was defined as patients' self-report of taking medications based on class I American College of Cardiology/American Heart Association guidelines for secondary prevention as defined, including antiplatelet agents, statins, and antihypertensive medications., Results: Among patients with atherothrombotic disease, 12 500 (48.6%) were deemed adherent to guideline-recommended medications. Adherent patients were younger, white, and had less polyvascular disease. Hispanic and East Asian patients were less likely to be adherent as compared with white patients (odds ratio [OR]: 0.72, 95% confidence interval [CI]: 0.59-0.88; and OR: 0.67, 95% CI: 0.53-0.83, respectively). Patients who had a nonfatal MI or underwent coronary angioplasty/stenting during follow-up were more likely to be adherent compared with patients without these events (OR: 1.73, 95% CI: 1.25-2.38; and OR: 2.15, 95% CI: 1.72-2.67, respectively). On the other hand, nonfatal stroke during follow-up was inversely associated with adherence (OR: 0.77, 95% CI: 0.61-0.97)., Conclusions: Using a large international registry of outpatients with atherothrombotic disease, we found that age, region, race/ethnicity, and incident cardiovascular events were predictive of long-term guideline adherence for secondary prevention, suggesting that certain patient groups may benefit from targeted interventions to improve adherence., (© 2013 Wiley Periodicals, Inc.)

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results